CRIPTO and its signaling partner GRP78 drive the metastatic phenotype in human osteotropic prostate cancer

CRIPTO (CR-1, TDGF1) is a cell surface/secreted oncoprotein actively involved in development and cancer. Here, we report that high expression of CRIPTO correlates with poor survival in stratified risk groups of prostate cancer (PCa) patients. CRIPTO and its signaling partner glucose-regulated protei...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncogene
Main Authors: Zoni, E, Chen, L, Karkampouna, S, Granchi, Z, Verhoef, E I, La Manna, F, Kelber, J, Pelger, R C M, Henry, M D, Snaar-Jagalska, E, van Leenders, G J L H, Beimers, L, Kloen, P, Gray, P C, van der Pluijm, G, Kruithof-de Julio, M
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2017
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5562855/
https://ncbi.nlm.nih.gov/pubmed/28394345
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/onc.2017.87
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados